Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
July 12 2022 - 07:28AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of July 2022
Commission
File Number: 001-39034
BELLUS
HEALTH INC.
(Name
of registrant)
275
Armand-Frappier Blvd.
Laval,
Québec
H7V
4A7
Canada
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
BELLUS
Health Inc. |
|
|
Date:
July 12, 2022 |
By: |
/s/
Ramzi Benamar |
|
|
Name:
Ramzi Benamar
Title: Chief Financial Officer |
Form
6-K Exhibit Index
BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From Feb 2024 to Mar 2024
BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From Mar 2023 to Mar 2024